About
Organogenesis Holdings Inc (NASDAQ:ORGO) — investor relations, events, news, and company updates on 6ix.
Latest News
Apr 6 2026
Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM
Apr 6 2026
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2026 Financial Results on May 7, 2026
Feb 26 2026
Organogenesis Holdings Inc. Reports Fourth Quarter 2025 Financial Results, Posts Record Revenue
Feb 19 2026
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2025 Financial Results on February 26, 2026
Dec 23 2025
Organogenesis Announces Initiation of Biologics License Application for ReNu®
Financials
Revenue
$564.17 M
Market Cap
$288.16 M
P/E Ratio
14.93
EPS
0.15
Translate